Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

ZEISS Medical Technology and Boehringer Ingelheim continue to advance their research collaboration to champion data-driven ...

Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment ...

Under Bayman's leadership, K&S's group of litigation practices has grown to 550 lawyers or almost half of the firm’s 1,300 ...

Boehringer Ingelheim, is a biopharmaceutical company, and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into a research ...

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include ...

Boehringer Ingelheim was an early adopter of Medidata's electronic data collection (EDC) platform for clinical trials, and has now extended and expanded the contract. The new five-year alliance ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Novus Diagnostics, an innovator in the field of rapid point-of-care diagnostics, announces the appointment of Dr. Margrit ...

IgA nephropathy (IgAN) is an autoimmune disorder that affects the kidneys by impairing the filtration function of the small ...

Explore the evolving landscape of non-small cell lung cancer (NSCLC) treatment, where targeted therapies address ten actionable genomic alterations (AGAs). Discover innovations in EGFR mutations, ...